Altamira Therapeutics Ltd. Investment Income
Altamira Therapeutics Ltd. (CYTOF) reported Investment Income of CHF 969 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-16.
Discontinued › Income Statement › Other Income
ifrs-full:InvestmentIncome · last filed 2023-05-16
| Period end | Investment Income 12 month |
|---|---|
| 2022-12-31 | 969.00 CHF 20-F · filed 2023-05-16 |
| 2021-12-31 | 3.22K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 258.00 CHF 20-F · filed 2023-05-16 |
| 2019-12-31 | 17.88K CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 0.00 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 53.57K CHF 20-F · filed 2020-04-16 |
| 2016-12-31 | 67.56K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 36.56K CHF 20-F · filed 2018-03-22 |